Items where authors include "Fitton, J"

Article

De Marco, G orcid.org/0000-0003-2406-161X, Giryes, S, Williams, K et al. (17 more authors) (2022) A Large Cluster of New Onset Autoimmune Myositis in the Yorkshire Region Following SARS-CoV-2 Vaccination. Vaccines, 10 (8). 1184. ISSN 2076-393X

Melville, AR, Yusof, Y, Fitton, J orcid.org/0000-0002-7795-8191 et al. (6 more authors) (2021) Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis. Rheumatology. ISSN 1462-0324

Fitton, J orcid.org/0000-0002-7795-8191, Melville, AR, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway. Rheumatology. ISSN 1462-0324

Kacar, M, Fitton, J orcid.org/0000-0002-7795-8191, Gough, AK et al. (3 more authors) (2020) Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease. RMD Open, 6 (2). e001246. ISSN 2056-5933

Fitton, J, Giollo, A and Buch, MH orcid.org/0000-0002-8962-5642 (2018) GP2015 as a promising therapy for rheumatoid arthritis. Expert Opinion on Biological Therapy, 18 (4). pp. 477-481. ISSN 1471-2598

Conference or Workshop Item

Dubash, S orcid.org/0000-0002-9303-7122, Bryer, D, Fitton, J et al. (4 more authors) (2018) Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis. In: Annual European Congress of Rheumatology (EULAR 2018), 13-16 Jun 2018, Amsterdam, Netherlands.

Dubash, S orcid.org/0000-0002-9303-7122, Bryer, D, Fitton, J et al. (4 more authors) (2018) Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis. In: Eleventh International Congress on Spondyloarthritides, 04-06 Oct 2018, Gent, Belgium.